CAP Cancer Protocols: September 2026 Update, CAP,
Esophageal and Esophagogastric Junction Cancers, NCCN,
Therapeutic Apheresis in Clinical Practice, ASFA,
Radiation Therapy for Bladder Cancer, ASTRO,
WHO Classification of Genetic Tumour Syndromes, WHO/IARC,
Connectome MRI and Clinical Data Protocols for Stroke, Parkinson's Disease, and Glioma, EAN,
Seasonal Respiratory Virus Vaccines in Immunocompromised Patients, IDSA,
Liquid Biopsy in Solid Tumours, ESP,
Medical Therapy for HR-Positive, HER2-Negative Early Breast Cancer, ASCO,
Primary Mediastinal B-Cell Lymphoma, BSH,
Cutaneous Toxicities of T-Cell-Redirecting Therapies in Multiple Myeloma, EADV,
Daraxonrasib for Metastatic Pancreatic Cancer, ESMO,
Advanced Gastroesophageal Cancer: Immunotherapy and Targeted Therapy, ASCO,
Cancer Survivorship, NCCN,
Stage IV NSCLC With Driver Alterations, ASCO,
Levodopa and Melanoma in Parkinson's Disease, MDS,
Radiation Therapy for Pancreatic Cancer, ASTRO,
Systemic Therapy for Metastatic Castration-Resistant Prostate Cancer, ASCO,
AGA Clinical Practice Update on Surveillance of Metaplastic and Premalignant Conditions of the Esophagus and Colorectum in Older Adults: Expert Review, AGA,
WHO Classification of Digestive System Tumours, WHO/IARC,
Lung Cancer Screening in Older Adults, SIOG,
Diagnosis of Light Chain Amyloidosis, ASH,
Optimising Prostate Stereotactic Body Radiotherapy, ESTRO,
International Classification of Diseases for Oncology, Fourth Edition, WHO/IARC,
High-Dose Thoracic Reirradiation for NSCLC, ESTRO,
Breast Cancer Follow-Up and Surveillance, ASCO,
Systemic Treatment of Recurrent Ovarian Cancer, ASCO,
Myeloproliferative Neoplasms, NCCN,
Focal Boost in Prostate Cancer Radiotherapy, ESTRO,
Frontline Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Reirradiation for Locally Recurrent Rectal Cancer, ESTRO (ASTRO-endorsed),
Treatment of Multiple Myeloma, ASCO,
Diagnosis, Treatment and Follow-Up of Hodgkin Lymphoma, EHA,
Sublobar Resection in Early-Stage Non-Small Cell Lung Cancer, STS,
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma, ASCO,
Acute Myeloid Leukemia, NCCN,
Cardiovascular Endpoints in Oncology Trials, AHA,
Management of Chronic Lymphocytic Leukemia and Richter Transformation, EHA,
Enhanced Recovery After Surgery in Gynecologic Oncology: 2026 Update, ERAS Society,
Exercise During and After Cancer Treatment in Children and Adolescents, ACSM,
Cardiovascular Disease in Adults With Cancer, IC-OS/MASCC,
Metastatic Breast Cancer, ESMO,
Stage IV NSCLC Without Driver Alterations, ASCO,
British Thoracic Society Quality Standard for Pleural Disease, BTS,
ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer, ERS/ESGE/ESTS,
Prostate Cancer, NCCN,
Early Diagnosis of Light Chain Amyloidosis, BSH,
Invasive Cutaneous Squamous Cell Carcinoma: Diagnosis and Prevention, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Treatment of Invasive Cutaneous Squamous Cell Carcinoma, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Multimodal Treatment of Pleural Mesothelioma, STS,
Breast Cancer Screening in Average-Risk Adult Females, ACP,
Clinically Localized Prostate Cancer, AUA/ASTRO,
Radiotherapy for Adult Soft Tissue Sarcoma, ESTRO (ASTRO-endorsed),
Transvaginal Ultrasonography for Postmenopausal Bleeding, ACOG,
AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review, AGA,
Screening for Cervical Cancer, ACOG,
Metastatic Colorectal Cancer, ESMO,
Topical Corticosteroids for Acute Radiation Dermatitis, MASCC,
Distress Management in Cancer Care, NCCN,
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC, IASLC,
Uveal Melanoma, ESMO/EURACAN,
Diagnosis and Management of Severe Acquired Aplastic Anemia, ASH,
Radiotherapy for Stage I–III Small Cell Lung Cancer, ESTRO/EORTC,
Systemic Treatment of Thyroid Cancer, ASCO,
Immunotherapy for Renal Cell Carcinoma, SITC,
2026 Prostate Cancer Guideline, EAU/EANM/ESTRO/ESUR/ISUP/SIOG,
Cancer in Pregnancy, SMFM,
Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, NCCN,
Patient-Clinician Communication in Cancer Care, ASCO,
Combining Radiotherapy With EGFR, ALK, or BRAF/MEK Inhibitors, ESMO/ESTRO,
White Blood Cell Growth Factors, ASCO,
Rectal Cancer Target Delineation and Dose Escalation, ESTRO,
WHO Reporting System for Soft Tissue Cytopathology, IAC/IARC/WHO,
AGA Clinical Practice Update on Management of Gastric Polyps: Expert Review, AGA,
Relapsed or Refractory Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Advanced and Metastatic Prostate Cancer, ESMO,
Coronary Atherosclerosis in Patients With Cancer and Survivors, AHA,
Hereditary Risk Assessment for Breast, Ovarian, Pancreatic, and Prostate Cancers, NCCN,
IMRT and Image Guidance for Rectal Cancer, ESTRO,
Interventions for Screen-Detected Lung Nodules, STS,
Positive hCG Results in Nonpregnant Patients Without Gynecologic Malignancy, ACOG,
Management of Epithelial Ovarian Cancer, ESMO,
Physical Exercise in Localized Colon Cancer, ESMO,
WHO Classification of Eye and Orbit Tumours, WHO/IARC,
Dose Constraints for Radiation Treatment Planning, ASTRO,
Small Cell Lung Cancer, NCCN,
Local and Regional Analgesia for Major Truncal Surgery, ASA,
Targeted Therapy in Inflammatory Arthritis After Cancer, EULAR,
Perioperative Venous Thromboembolism Prophylaxis, ESAIC and partner societies,
